Status: open
Cephalon, Inc (Provigil®)
Defendant: Cephalon, Inc
Consumers who bought certain dosages of Provigil® and/or its generic version between June 24, 2006 and August 8, 2019 may be eligible for payment. The companies reached a settlement over allegations of antitrust violations.